Jan 12 (Reuters) - Combigene Ab:
* COMBIGENE AND CELL AND GENE THERAPY CATAPULT SIGN AGREEMENT TO DEVELOP MANUFACTURING PROCESS FOR NOVEL GENE THERAPY TO TREAT EPILEPSY Source text for Eikon: Further company coverage: (Gdynia Newsroom)
 